Risk factor
Good trading liquidity
Profitability factor
Very favourable analyst view
About
Operating within China, Beijing Aosaikang Pharmaceutical Co., Ltd. specializes in the research, development, production, and sale of pharmaceuticals, fine chemicals, and health products. Its diverse offerings include proton pump inhibitor injections, oncology medications, and active pharmaceutical ingredients (APIs), which are applied across key therapeutic areas like digestive disorders, cancer treatment, and infectious diseases. The company was founded in 2003 and is headquartered in Nanjing, China.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA,
Target Price
The average target price of 002755.SZ is 26.3 and suggests 106% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to